Pearl Moharil

502 total citations
10 papers, 399 citations indexed

About

Pearl Moharil is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Pearl Moharil has authored 10 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biomedical Engineering, 4 papers in Biomaterials and 2 papers in Molecular Biology. Recurrent topics in Pearl Moharil's work include Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and RNA Interference and Gene Delivery (2 papers). Pearl Moharil is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and RNA Interference and Gene Delivery (2 papers). Pearl Moharil collaborates with scholars based in United States, China and India. Pearl Moharil's co-authors include Amit Kumar Jaiswal, Zhuoya Wan, Jingjing Sun, Song Li, Runzi Sun, Carlos Muñóz-Garay, Manikandan Anandhan, Sivakumar Arumugam, Xu Song and Qiang Ao and has published in prestigious journals such as Scientific Reports, Science Advances and Molecules.

In The Last Decade

Pearl Moharil

9 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pearl Moharil United States 8 177 156 105 74 60 10 399
Christin Neuber Germany 12 129 0.7× 90 0.6× 222 2.1× 48 0.6× 31 0.5× 43 573
Juan Fan China 18 156 0.9× 245 1.6× 231 2.2× 114 1.5× 32 0.5× 38 785
Xu Liao China 9 119 0.7× 138 0.9× 122 1.2× 79 1.1× 30 0.5× 16 354
Smrithi Padmakumar United States 14 116 0.7× 154 1.0× 130 1.2× 90 1.2× 28 0.5× 15 407
Heping Wang China 11 122 0.7× 67 0.4× 263 2.5× 46 0.6× 45 0.8× 25 536
Xianglin Fan China 13 116 0.7× 149 1.0× 256 2.4× 164 2.2× 30 0.5× 20 549
Mark Martin Jensen United States 10 99 0.6× 147 0.9× 107 1.0× 47 0.6× 24 0.4× 22 472
Hany E. Marei Egypt 11 137 0.8× 129 0.8× 141 1.3× 43 0.6× 70 1.2× 19 527
Arturo J. Vegas United States 8 107 0.6× 64 0.4× 121 1.2× 78 1.1× 25 0.4× 12 338

Countries citing papers authored by Pearl Moharil

Since Specialization
Citations

This map shows the geographic impact of Pearl Moharil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pearl Moharil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pearl Moharil more than expected).

Fields of papers citing papers by Pearl Moharil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pearl Moharil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pearl Moharil. The network helps show where Pearl Moharil may publish in the future.

Co-authorship network of co-authors of Pearl Moharil

This figure shows the co-authorship network connecting the top 25 collaborators of Pearl Moharil. A scholar is included among the top collaborators of Pearl Moharil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pearl Moharil. Pearl Moharil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Luther, Kristin, Ali Navaei, Pearl Moharil, et al.. (2025). Scalable production and purification of engineered ARRDC1-mediated microvesicles in a HEK293 suspension cell system. Scientific Reports. 15(1). 7299–7299. 1 indexed citations
2.
Moharil, Pearl, Natalie Boehnke, Richard Panayiotou, et al.. (2022). Synergistic combination therapy delivered via layer‐by‐layer nanoparticles induces solid tumor regression of ovarian cancer. Bioengineering & Translational Medicine. 8(2). e10429–e10429. 11 indexed citations
3.
Moharil, Pearl, Zhuoya Wan, Jiang Li, et al.. (2021). Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages. Acta Pharmaceutica Sinica B. 12(3). 1148–1162. 53 indexed citations
4.
Wan, Zhuoya, Runzi Sun, Yang‐Wuyue Liu, et al.. (2021). Targeting metabotropic glutamate receptor 4 for cancer immunotherapy. Science Advances. 7(50). eabj4226–eabj4226. 23 indexed citations
5.
Wan, Zhuoya, Pearl Moharil, Yuzhe Liu, et al.. (2021). Polymeric Micelles in Cancer Immunotherapy. Molecules. 26(5). 1220–1220. 32 indexed citations
6.
Wan, Zhuoya, Runzi Sun, Pearl Moharil, et al.. (2020). Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia. Journal of Leukocyte Biology. 109(2). 425–436. 18 indexed citations
7.
Wan, Zhuoya, Jingjing Sun, Jieni Xu, et al.. (2019). Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy. Acta Biomaterialia. 90. 300–313. 51 indexed citations
8.
Wan, Zhuoya, Jingjing Sun, Jieni Xu, et al.. (2019). Dual Functional Immunostimulatory Polymeric Prodrug Carrier with Pendent Indoximod for Enhanced Cancer Immunochemotherapy. SSRN Electronic Journal. 1 indexed citations
10.
Moharil, Pearl, et al.. (2017). Biomaterials and cells for cardiac tissue engineering: Current choices. Materials Science and Engineering C. 79. 950–957. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026